ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.72
0.00%
US Tech 100
20,850.40
-0.25%
S&P 500
5,970.84
-1.11%
US Dollar vs CAD
1.43747
-0.21%
Bitcoin
93,931.31
0.44%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Vor Biopharma Inc (VOR) Share Price

Vor Biopharma Inc

Vor Biopharma Inc (VOR)

Vortiv Limited
1.27
0.43
(51.55%)
Closed December 27 3:00PM
Delayed by 15 minutes
1.16
-0.11
( -8.66% )
Pre Market: 6:11AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
1.16
Bid
1.15
Ask
1.24
Volume
55,132
0.00 Day's Range 0.00
0.6354 52 Week Range 3.1399
Market Cap
79.661M
Previous Close
1.27
Open
-
Last Trade
340
@
1.16
(formt)
Last Trade Time
06:11:00
Financial Volume
-
VWAP
-
Average Volume (3m)
632,204
Shares Outstanding
68,673,612
Dividend Yield
-
PE Ratio
-0.74
Earnings Per Share (EPS)
-1.72
Revenue
-
Net Profit
-117.86M

About Vor Biopharma Inc

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33. Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.vorbio.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Vor Biopharma Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker VOR. The last closing price for Vor Biopharma was US$1.27. Over the last year, Vor Biopharma shares have traded in a share price range of US$ 0.6354 to US$ 3.1399.

Vor Biopharma currently has 68,673,612 shares outstanding. The market capitalization of Vor Biopharma is US$87.22 million. Vor Biopharma has a price to earnings ratio (PE ratio) of -0.74.

Ask ADVFN Intelligence (AI)

VOR Latest News

More News

Form 8-K - Current report

December 27 2024
Edgar (US Regulatory)

Vor Bio Announces $55.6 Million Private Placement

Intend to announce updated clinical data from Phase 1/2 VBP301 trial of VCAR33ALLO in the first half of 2025 and updated clinical data from Phase 1/2a VBP101 trial of trem-cel in combination with...

December 27 2024
GlobeNewswire Inc.

Form 8-K - Current report

December 09 2024
Edgar (US Regulatory)

Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design

Preliminary data suggests improved relapse-free survival compared to published groups of acute myeloid leukemia (AML) patients at high risk of relapse post-transplantTrem-cel + Mylotarg continue...

December 09 2024
GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

November 14 2024
Edgar (US Regulatory)

Vor Bio to Participate in the Stifel 2024 Healthcare Conference

CAMBRIDGE, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in a fireside chat and...

November 12 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

November 08 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

November 08 2024
Edgar (US Regulatory)

Vor Bio Reports Third Quarter 2024 Financial Results and Provides Company Update

Company to present trem-cel + Mylotarg clinical data update at American Society of Hematology (ASH) 2024 annual meetingHan Choi, M.D., LL.M, seasoned healthcare institutional investor, appointed...

November 07 2024
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

November 07 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.30936.31022326670.8511.620.819218831501.22286373CS
40.3136.47058823530.851.620.88980851.07999337CS
120.4870.58823529410.681.620.63546322040.92975289CS
260.1312.62135922331.031.620.63547041830.9130393CS
52-1.09-48.44444444442.253.13990.63545168241.18450615CS
156-10.51-90.05998286211.6712.730.63542619252.43875258CS
260-40.86-97.239409804942.0263.620.63542398716.29085048CS

VOR - Frequently Asked Questions (FAQ)

What is the current Vor Biopharma share price?
The current share price of Vor Biopharma is US$ 1.16
How many Vor Biopharma shares are in issue?
Vor Biopharma has 68,673,612 shares in issue
What is the market cap of Vor Biopharma?
The market capitalisation of Vor Biopharma is USD 87.22M
What is the 1 year trading range for Vor Biopharma share price?
Vor Biopharma has traded in the range of US$ 0.6354 to US$ 3.1399 during the past year
What is the PE ratio of Vor Biopharma?
The price to earnings ratio of Vor Biopharma is -0.74
What is the reporting currency for Vor Biopharma?
Vor Biopharma reports financial results in USD
What is the latest annual profit for Vor Biopharma?
The latest annual profit of Vor Biopharma is USD -117.86M
What is the registered address of Vor Biopharma?
The registered address for Vor Biopharma is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Vor Biopharma website address?
The website address for Vor Biopharma is www.vorbio.com
Which industry sector does Vor Biopharma operate in?
Vor Biopharma operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WATTEnergous Corporation
US$ 1.54
(274.51%)
41.27M
NXUNXU Inc
US$ 0.5585
(129.46%)
29.83M
INTZIntrusion Inc
US$ 4.15
(92.13%)
18.95M
VINCVincerx Inc
US$ 0.3074
(58.45%)
15.66M
OCTOEightco Holdings Inc
US$ 2.52
(57.50%)
657.75k
LITMSnow Lake Resources Ltd
US$ 1.02
(-36.25%)
6.97M
AILEiLearningEngines Inc
US$ 0.451
(-23.97%)
1.16M
RPAYRepay Holdings Corporation
US$ 6.01
(-22.35%)
1
LINCLincoln Educational Services Corp
US$ 12.01
(-22.11%)
9
HUBCWHub Cyber Security Ltd
US$ 0.0273
(-22.00%)
71.02k
WATTEnergous Corporation
US$ 1.54
(274.51%)
41.27M
NXUNXU Inc
US$ 0.5585
(129.46%)
29.83M
INTZIntrusion Inc
US$ 4.15
(92.13%)
18.95M
SMXSMX Security Matters Public Company
US$ 0.4991
(41.15%)
18.18M
VINCVincerx Inc
US$ 0.3074
(58.45%)
15.66M

VOR Discussion

View Posts
PonkenPlonken PonkenPlonken 3 days ago
close above 200??
👍️0
PonkenPlonken PonkenPlonken 3 days ago
Money goes where its treated best.... now imagine what the stock can do on actual data
👍️0
PonkenPlonken PonkenPlonken 3 days ago
not bad
still looking for a VINC move! waiting for the unveil
👍️0
PonkenPlonken PonkenPlonken 3 days ago
GOOD stuff - remember traded at .8s last weeks

Vor Bio will issue an aggregate of 55,871,260 shares of common stock and accompanying warrants to purchase an aggregate of 69,839,075 shares of common stock at a combined price of $0.99425 per share and accompanying warrants. The warrants will have a per share exercise price of $0.838 and may be exercised at any time on or after the closing date and through the seventh anniversary of the closing date
https://www.globenewswire.com/news-release/2024/12/27/3002259/0/en/Vor-Bio-Announces-55-6-Million-Private-Placement.html
👍️0
PonkenPlonken PonkenPlonken 2 weeks ago
beam me up scotty
👍️0
PonkenPlonken PonkenPlonken 2 weeks ago
readying here
👍️0
PonkenPlonken PonkenPlonken 2 months ago
VINC type move coming
👍️0
PonkenPlonken PonkenPlonken 2 months ago
super super undervalued. Sid Mukherjee - gifted founder. Couple with recent clinical validation...
Problem in AML is not the drugs efficacy rather the possibility to handle the drug. They might just fix that.
👍️0
PonkenPlonken PonkenPlonken 2 months ago
good dip buy
👍️0
PonkenPlonken PonkenPlonken 4 months ago
The buyers of all these shares arent going anywhere. Waiting for it to unfold.
All the traders didnt understand this prudent PR? You dont need fluffy if you have the real deal
👍️0
PonkenPlonken PonkenPlonken 4 months ago
remember this was founded to heal patients, not retire the management. This is a mission by the brilliant founder and the $$ will come as a by product of things being very right.
👍️0
PonkenPlonken PonkenPlonken 4 months ago
Helps where CAR T cant in AML. Its about giving MORE of the drugs that heal..... they work but the body cant handle them. With VOR, it can.

People might just start realizing how huge the possibilities for this are.... GIVEN: r/r AML makes up 40-50% in younger patients and the great majority of elderly patients.
Now experiment with the 20bn TAM for r/r AML and some funny numbers start popping up.
Look at the founder... hes onto something.

the actual data will speak soon. The investigator is ultra optimistic.... he likely saw more.
👍️0
glenn1919 glenn1919 4 months ago
VOR................................https://stockcharts.com/h-sc/ui?s=VOR&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 6 months ago
VOR new 52 week low
👍️0
Monksdream Monksdream 6 months ago
VOR new 52 week low
👍️0
PonkenPlonken PonkenPlonken 6 months ago
Sid Mukherjee saw the potential in Saar Gills and Carl Junes approach and funded VOR==== shielding the right cells and attacking the cancer. For simplicity, it could be summed up as bottom up selectivity.................
Very different from all the other CAR T stuff out there that is pretty much top-down-y. And in my opinion, top down systems dont work.
5am and RA certainly think so. Will go back to the IPO price and then some is my bet.
👍️0
Monksdream Monksdream 6 months ago
GNPX new 52 week low

👍️0
PonkenPlonken PonkenPlonken 6 months ago
Im starting to think someone just buys them out.
Interesting action yesterday.
👍️0
Monksdream Monksdream 7 months ago
VOR new 52 week low
👍️0
Monksdream Monksdream 7 months ago
VOR new 52 week low
👍️0
PonkenPlonken PonkenPlonken 7 months ago
elevated volume for quite some time now.
👍️0
PonkenPlonken PonkenPlonken 8 months ago
https://en.wikipedia.org/wiki/Siddhartha_Mukherjee founder is a smart man. They can do Car T without the tox.
👍️0
Monksdream Monksdream 9 months ago
VORBunder $2
👍️0
glenn1919 glenn1919 10 months ago
VOR.....................................https://stockcharts.com/h-sc/ui?s=VOR&p=W&b=5&g=0&id=p86431144783
👍️0

Your Recent History

NASDAQ
VOR
Vor Biopharma
LSE
AZ56
Barrow Fnd.62 S
LSE
72PE
07dec2030c
LSE
57ME
Tower 21-1 64
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads